Fellows Fund Invests in Abridge AI! We're thrilled to announce Fellows Fund's investment in Abridge, a premier Healthcare AI company that is revolutionizing clinical documentation through its cutting-edge generative AI platform. This innovative solution is already being used at over 100 of the nation's largest health systems, including Johns Hopkins, Mayo Clinic, Duke Health, Memorial Sloan Kettering, and many others. Abridge's new Contextual Reasoning Engine integrates clinical insights, patient histories, and revenue cycle guidelines, generating accurate, billable notes instantly at the point of care—improving clinician productivity and patient outcomes. Charles Elkan, Venture Partner & Distinguished Fellow at Fellows Fund: "Abridge's AI platform is reshaping clinical documentation with unparalleled accuracy, significantly enhancing provider and patient experiences across diverse care settings. Their proven deployment at leading health institutions underscores their transformative impact." Anshul Pande, EVP at HealthEdge & Distinguished Fellow at Fellows Fund: "You take notice when your own physician uses Abridge. Deeper patient interactions, more accurate documentation, improved outcomes, and reduced clinician burnout—Abridge meaningfully addresses the critical challenges in healthcare today." At Fellows Fund, we're committed to supporting groundbreaking vertical AI solutions, especially in healthcare, where AI dramatically improves efficiency, safety, and patient care.
🚀 𝗠𝗮𝗷𝗼𝗿 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀: New Abridge Contextual Reasoning Engine, $250M Series D, and 100+ enterprise customers. 📈 Streamlined clinical and financial workflows, powered by the new Abridge Contextual Reasoning Engine 🤝 $250M Series D round, led by investors Elad Gil and IVP (click below for the full list of investors) 🙏 Privileged to serve 100+ of the largest health systems “We aspire to serve our health system partners for the decades to come. This investment supports that aspiration, as well as the core research and development that differentiates our approach.” —Dr. Shivdev Rao, CEO and Founder of Abridge Read more —> https://lnkd.in/e6h--aNP
